1. Home
  2. EVOK vs NXU Comparison

EVOK vs NXU Comparison

Compare EVOK & NXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • NXU
  • Stock Information
  • Founded
  • EVOK 2007
  • NXU 2016
  • Country
  • EVOK United States
  • NXU United States
  • Employees
  • EVOK N/A
  • NXU N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • NXU Automotive Aftermarket
  • Sector
  • EVOK Health Care
  • NXU Consumer Discretionary
  • Exchange
  • EVOK Nasdaq
  • NXU Nasdaq
  • Market Cap
  • EVOK 7.1M
  • NXU 8.6M
  • IPO Year
  • EVOK 2013
  • NXU 2022
  • Fundamental
  • Price
  • EVOK $5.07
  • NXU $0.31
  • Analyst Decision
  • EVOK
  • NXU
  • Analyst Count
  • EVOK 0
  • NXU 0
  • Target Price
  • EVOK N/A
  • NXU N/A
  • AVG Volume (30 Days)
  • EVOK 8.5K
  • NXU 26.1M
  • Earning Date
  • EVOK 03-13-2025
  • NXU 03-31-2025
  • Dividend Yield
  • EVOK N/A
  • NXU N/A
  • EPS Growth
  • EVOK N/A
  • NXU N/A
  • EPS
  • EVOK N/A
  • NXU N/A
  • Revenue
  • EVOK $8,617,036.00
  • NXU $396,000.00
  • Revenue This Year
  • EVOK $97.35
  • NXU N/A
  • Revenue Next Year
  • EVOK $99.52
  • NXU N/A
  • P/E Ratio
  • EVOK N/A
  • NXU N/A
  • Revenue Growth
  • EVOK 100.35
  • NXU 238.46
  • 52 Week Low
  • EVOK $3.54
  • NXU $0.21
  • 52 Week High
  • EVOK $12.32
  • NXU $2.25
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 55.10
  • NXU 43.78
  • Support Level
  • EVOK $4.68
  • NXU $0.33
  • Resistance Level
  • EVOK $5.40
  • NXU $0.41
  • Average True Range (ATR)
  • EVOK 0.31
  • NXU 0.07
  • MACD
  • EVOK 0.03
  • NXU 0.00
  • Stochastic Oscillator
  • EVOK 57.85
  • NXU 22.65

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About NXU Nxu Inc.

Nxu Inc is a technology company developing next-generation electric vehicle (EV) charging, battery, and vehicle technologies for mobility customers. Its technology company building energy and infrastructure solutions for consumers and businesses. Its NxuOne charging technology provides repeatable, consistent power delivery, designed to meet the needs of today's electric vehicles as well as those developed in the future.

Share on Social Networks: